tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

IMRX Stock Latest News

Immuneering launches Pancreatic Cancer Advisory Board
The FlyImmuneering launches Pancreatic Cancer Advisory Board
2d ago
IMRX
Immuneering to present data from Phase 2a trial of IMM-1-104 in early January
PremiumThe Fly
Immuneering to present data from Phase 2a trial of IMM-1-104 in early January
4d ago
IMRX
Immuneering downgraded to Underweight from Equal Weight at Morgan Stanley
PremiumThe Fly
Immuneering downgraded to Underweight from Equal Weight at Morgan Stanley
8d ago
IMRX
Immuneering granted FDA Fast Track designation for IMM-1-104
PremiumThe Fly
Immuneering granted FDA Fast Track designation for IMM-1-104
9d ago
IMRX
Immuneering Corp. Reports Q3 Loss, Highlights Progress
PremiumCompany Announcements
Immuneering Corp. Reports Q3 Loss, Highlights Progress
1M ago
IMRX
Immuneering reports Q3 EPS (49c), consensus (55c)
PremiumThe FlyImmuneering reports Q3 EPS (49c), consensus (55c)
1M ago
IMRX
Immuneering granted Orphan Drug Designation for IMM-1-104
Premium
The Fly
Immuneering granted Orphan Drug Designation for IMM-1-104
2M ago
IMRX
Immuneering treatment of pancreatic cancer granted FDA orphan status
Premium
The Fly
Immuneering treatment of pancreatic cancer granted FDA orphan status
2M ago
IMRX
3 Penny Stocks to Watch Now, 9/18/24
PremiumMarket News
3 Penny Stocks to Watch Now, 9/18/24
3M ago
DTSS
IMRX
Morning Movers: Boeing slips following Seattle factory workers’ strike
PremiumThe Fly
Morning Movers: Boeing slips following Seattle factory workers’ strike
3M ago
BA
RH
Immuneering price target raised to $13 from $12 at Chardan
PremiumThe Fly
Immuneering price target raised to $13 from $12 at Chardan
3M ago
IMRX
Immuneering announces initial response data from first five IMM-1-104 patients
PremiumThe Fly
Immuneering announces initial response data from first five IMM-1-104 patients
3M ago
IMRX
Immuneering price target lowered to $12 from $16 at Chardan
PremiumThe FlyImmuneering price target lowered to $12 from $16 at Chardan
5M ago
IMRX
Immuneering receives fast track designation for IMM-1-104 from FDA
Premium
The Fly
Immuneering receives fast track designation for IMM-1-104 from FDA
5M ago
IMRX
Immuneering reports Q1 EPS (49c), consensus (50c)
Premium
The Fly
Immuneering reports Q1 EPS (49c), consensus (50c)
8M ago
IMRX
Immuneering presents preclinical data on IMM-1-104 at AACR 2024
PremiumThe Fly
Immuneering presents preclinical data on IMM-1-104 at AACR 2024
9M ago
IMRX
Immuneering price target lowered to $8 from $20 at Mizuho
PremiumThe Fly
Immuneering price target lowered to $8 from $20 at Mizuho
9M ago
IMRX
Immuneering announces first patient dosed in Phase 1/2 trial of IMM-6-415
PremiumThe Fly
Immuneering announces first patient dosed in Phase 1/2 trial of IMM-6-415
9M ago
IMRX
Immuneering price target lowered to $15 from $20 at Needham
PremiumThe Fly
Immuneering price target lowered to $15 from $20 at Needham
9M ago
IMRX
Immuneering price target lowered to $16 from $21 at Chardan
PremiumThe FlyImmuneering price target lowered to $16 from $21 at Chardan
9M ago
IMRX
Immuneering downgraded to Hold from Buy at Jefferies
Premium
The Fly
Immuneering downgraded to Hold from Buy at Jefferies
9M ago
IMRX
Immuneering downgraded to Market Perform from Outperform at TD Cowen
Premium
The Fly
Immuneering downgraded to Market Perform from Outperform at TD Cowen
9M ago
IMRX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >